NELLCOR PURITAN BENNETT IRELAND UNLIMITED COMPANY
Location
Founded
1989-05-15
Website
Risk Signals
8568 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about NELLCOR PURITAN BENNETT IRELAND UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2024-09-05 (medtechdive.com)
European heart group recommends renal denervation for some patients
The European Society of Cardiology said the treatment may be considered for certain patients with uncontrolled, drug-resistant high blood pressure but outlined lingering concerns.
Read more
2024-08-31 (massdevice.com)
Medtronic applauds European support for renal denervation
Medtronic praised new European Society of Cardiology (ESC) 2024 guidelines for renal denervation (RDN) procedures for hypertension.
Read more
2024-06-19 (expresshealthcare.in)
Abbott to compete with Medtronic in EU dual-chamber leadless pacemaker market: GlobalData
The global dual chamber leadless pacemaker market is poised to grow at a CAGR of 8.95 per cent from $185.9 million in 2023 to $438 million in 2033, forecasts GlobalData
Read more
2024-02-01 (neuronewsinternational.com)
Medtronic announces first neurointerventional case with CE-marked Rist 6Fr radial access catheter
Medtronic has announced the first neurointerventional case in Europe with its Rist 6Fr radial access catheter, which recently received regulatory approval for use in European Union (EU) countries and other geographies accepting a CE mark.
Read more
2023-10-25 (medtechintelligence.com)
EU MDR and IVDR
EU MDR requires significant reforms to the device labeling process. Manufacturers must ensure that
Read more
2023-08-01 (massdevice.com)
FDA clears BD combo test for COVID-19, flu, RSV
BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its respiratory viral panel (RVP).
Read more
2023-06-13 (massdevice.com)
Gore initiates study to compare VBX stent graft, metal stenting
Gore announced that it initiated a clinical study comparing its VBX stent graft to bare metal stenting in complex iliac occlusive disease.
Read more
2016-09-09 (startribune.com)
Medtronic, now based in Ireland, still reaps U.S. benefits
Since its "inversion," the company has been awarded more than $40 million in federal contracts and its executives still work at its Fridley campus.
Read more
2016-05-30 (analist.be)
EU figures on Tuesday, including Medtronic and Volkswagen
Here you can see the planned publications of European companies - May 30
Read more
2015-07-13 (proactiveinvestors.com)
Dow Jones soars 200 plus points
Wall Street rallied today as investors turned optimistic after eurozone leaders, over the weekend, reached an agreement for a third bailout program for...
Read more
2014-01-07 (tctmd.com)
1st Generation DES Are Less Cost-Effective Than SMD Oral Rapamycin at 5 Years
An oral strategy of oral rapamycin plus bare metal stents (BMS) is more cost-effective at 5 years than using first-generation drug-eluting stents (DES), according to a study published online on December 16, 2013, prior to its print edition in the American Journal of Cardiology.
Read more
2012-10-29 (marketwatch.com)
Medtronic: New data mean likely EU OK for device
Medtronic Inc. MDT released new data on an investigational heart valve replacement device that could help it in its battle with Edwards Lifesciences Inc. EW for market share in Europe. The new device, called Engager, was shown in a company-funded study to be effective and safe, clearing the way for
Read more